Logo image of ADN.CA

ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ADN - CA0042721005 - Common Stock

15.75 CAD
+0.15 (+0.96%)
Last: 12/10/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ADN scores 4 out of 10 in our fundamental rating. ADN was compared to 11 industry peers in the Paper & Forest Products industry. ADN has an excellent profitability rating, but there are concerns on its financial health. ADN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ADN was profitable.
In the past year ADN had a positive cash flow from operations.
In the past 5 years ADN has always been profitable.
ADN had a positive operating cash flow in each of the past 5 years.
ADN.CA Yearly Net Income VS EBIT VS OCF VS FCFADN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.36%, ADN belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
ADN has a Return On Equity of 4.19%. This is amongst the best in the industry. ADN outperforms 81.82% of its industry peers.
ADN has a better Return On Invested Capital (1.63%) than 81.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADN is in line with the industry average of 4.51%.
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROIC 1.63%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ADN.CA Yearly ROA, ROE, ROICADN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ADN has a Profit Margin of 16.03%. This is amongst the best in the industry. ADN outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of ADN has grown nicely.
ADN's Operating Margin of 15.01% is amongst the best of the industry. ADN outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of ADN has declined.
ADN has a better Gross Margin (30.11%) than 100.00% of its industry peers.
ADN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
ADN.CA Yearly Profit, Operating, Gross MarginsADN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN is destroying value.
ADN has more shares outstanding than it did 1 year ago.
ADN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ADN is higher compared to a year ago.
ADN.CA Yearly Shares OutstandingADN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADN.CA Yearly Total Debt VS Total AssetsADN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that ADN is in the distress zone and has some risk of bankruptcy.
ADN has a Altman-Z score of 1.13. This is comparable to the rest of the industry: ADN outperforms 45.45% of its industry peers.
ADN has a debt to FCF ratio of 32.89. This is a negative value and a sign of low solvency as ADN would need 32.89 years to pay back of all of its debts.
The Debt to FCF ratio of ADN (32.89) is better than 63.64% of its industry peers.
ADN has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
ADN has a Debt to Equity ratio of 0.33. This is in the better half of the industry: ADN outperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Altman-Z 1.13
ROIC/WACC0.26
WACC6.21%
ADN.CA Yearly LT Debt VS Equity VS FCFADN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ADN has a Current Ratio of 0.96. This is a bad value and indicates that ADN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.96, ADN is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
ADN has a Quick Ratio of 0.96. This is a bad value and indicates that ADN is not financially healthy enough and could expect problems in meeting its short term obligations.
ADN's Quick ratio of 0.88 is fine compared to the rest of the industry. ADN outperforms 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.88
ADN.CA Yearly Current Assets VS Current LiabilitesADN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

The earnings per share for ADN have decreased strongly by -48.15% in the last year.
ADN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.80% yearly.
Looking at the last year, ADN shows a very negative growth in Revenue. The Revenue has decreased by -28.86% in the last year.
Measured over the past years, ADN shows a small growth in Revenue. The Revenue has been growing by 3.05% on average per year.
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%

3.2 Future

ADN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.83% yearly.
Based on estimates for the next years, ADN will show a decrease in Revenue. The Revenue will decrease by -3.68% on average per year.
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN.CA Yearly Revenue VS EstimatesADN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ADN.CA Yearly EPS VS EstimatesADN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.75, ADN is valued on the expensive side.
Based on the Price/Earnings ratio, ADN is valued cheaper than 81.82% of the companies in the same industry.
ADN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.59.
The Price/Forward Earnings ratio is 21.07, which indicates a rather expensive current valuation of ADN.
Based on the Price/Forward Earnings ratio, ADN is valued a bit cheaper than 63.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.80. ADN is around the same levels.
Industry RankSector Rank
PE 18.75
Fwd PE 21.07
ADN.CA Price Earnings VS Forward Price EarningsADN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ADN's Enterprise Value to EBITDA ratio is in line with the industry average.
ADN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ADN is cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 85.56
EV/EBITDA 27.63
ADN.CA Per share dataADN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

ADN has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as ADN's earnings are expected to decrease with -10.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.48%, ADN is a good candidate for dividend investing.
ADN's Dividend Yield is rather good when compared to the industry average which is at 4.13. ADN pays more dividend than 100.00% of the companies in the same industry.
ADN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 7.48%

5.2 History

The dividend of ADN decreases each year by -10.56%.
ADN has been paying a dividend for at least 10 years, so it has a reliable track record.
ADN has decreased its dividend recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
ADN.CA Yearly Dividends per shareADN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

73.33% of the earnings are spent on dividend by ADN. This is not a sustainable payout ratio.
ADN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.33%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
ADN.CA Yearly Income VS Free CF VS DividendADN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
ADN.CA Dividend Payout.ADN.CA Dividend Payout, showing the Payout Ratio.ADN.CA Dividend Payout.PayoutRetained Earnings

ACADIAN TIMBER CORP

TSX:ADN (12/10/2025, 7:00:00 PM)

15.75

+0.15 (+0.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-10 2026-02-10
Inst Owners8.5%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap288.07M
Revenue(TTM)85.21M
Net Income(TTM)14.13M
Analysts76.67
Price Target18.11 (14.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.48%
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP73.33%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-31 2025-12-31 (0.29)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.32%
Min EPS beat(2)-40.59%
Max EPS beat(2)29.95%
EPS beat(4)2
Avg EPS beat(4)36.33%
Min EPS beat(4)-40.59%
Max EPS beat(4)164.03%
EPS beat(8)5
Avg EPS beat(8)101.8%
EPS beat(12)9
Avg EPS beat(12)176.18%
EPS beat(16)11
Avg EPS beat(16)130.41%
Revenue beat(2)1
Avg Revenue beat(2)-9.79%
Min Revenue beat(2)-31.34%
Max Revenue beat(2)11.76%
Revenue beat(4)1
Avg Revenue beat(4)-7.73%
Min Revenue beat(4)-31.34%
Max Revenue beat(4)11.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.15%
Revenue beat(16)6
Avg Revenue beat(16)-0.65%
PT rev (1m)-8.97%
PT rev (3m)-8.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-37.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.33%
Valuation
Industry RankSector Rank
PE 18.75
Fwd PE 21.07
P/S 3.27
P/FCF 85.56
P/OCF 41.21
P/B 0.86
P/tB 0.87
EV/EBITDA 27.63
EPS(TTM)0.84
EY5.33%
EPS(NY)0.75
Fwd EY4.75%
FCF(TTM)0.18
FCFY1.17%
OCF(TTM)0.38
OCFY2.43%
SpS4.82
BVpS18.41
TBVpS18.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.65
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROCE 2.27%
ROIC 1.63%
ROICexc 1.64%
ROICexgc 1.65%
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
FCFM 3.82%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexgc growth 3Y0.45%
ROICexgc growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Debt/EBITDA 7.67
Cap/Depr 328.17%
Cap/Sales 4.11%
Interest Coverage 3.75
Cash Conversion 48.76%
Profit Quality 23.84%
Current Ratio 0.96
Quick Ratio 0.88
Altman-Z 1.13
F-Score3
WACC6.21%
ROIC/WACC0.26
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A
EBIT growth 1Y-48.28%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year-37.55%
EBIT Next 3Y3.4%
EBIT Next 5YN/A
FCF growth 1Y-70.57%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y-41.26%
OCF growth 3Y28.01%
OCF growth 5YN/A

ACADIAN TIMBER CORP / ADN.CA FAQ

What is the ChartMill fundamental rating of ACADIAN TIMBER CORP (ADN.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ADN.CA.


What is the valuation status for ADN stock?

ChartMill assigns a valuation rating of 4 / 10 to ACADIAN TIMBER CORP (ADN.CA). This can be considered as Fairly Valued.


How profitable is ACADIAN TIMBER CORP (ADN.CA) stock?

ACADIAN TIMBER CORP (ADN.CA) has a profitability rating of 8 / 10.


How financially healthy is ACADIAN TIMBER CORP?

The financial health rating of ACADIAN TIMBER CORP (ADN.CA) is 3 / 10.


Can you provide the dividend sustainability for ADN stock?

The dividend rating of ACADIAN TIMBER CORP (ADN.CA) is 5 / 10 and the dividend payout ratio is 73.33%.